Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0824589B1 Utrophin gene promoter
12/10/2003EP0824547B1 Anti-fungal peptides
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0724641B1 Anti-microbial proteins
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B
12/10/2003CN1461309A Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461187A Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes
12/10/2003CN1130566C Reagent kit and method for simultaneous diagnosis of hepatitis B and C
12/10/2003CN1130459C Biological active molecules having potentiating effect on growth hormone biological activity
12/10/2003CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
12/10/2003CN1130225C Method for purifying necrotoxin produced by bordetella and toxoid
12/10/2003CN1130224C Low sugar content, stabilized, albumin-free recombinant coagulation factor preparation
12/10/2003CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
12/10/2003CN1130130C Semi-dry microwave synthesis process of phosphoprotein
12/10/2003CA2389911A1 Broad spectruma antagonists and vaccines directed against pyrogenic exotoxins
12/09/2003US6660914 Transformed cotton plants
12/09/2003US6660908 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor
12/09/2003US6660907 Genes encoding SCIP-1 orthologs and methods of use
12/09/2003US6660906 Tpl2 transgenic knockout mice
12/09/2003US6660904 Identifying a compound which modulates effects of HIV-1 infection in a cell
12/09/2003US6660851 DNA fragment elevating gene expression dose
12/09/2003US6660848 Signal Transducer and Activator of Transcription (STAT) proteins are a new class of intracellular transcription factors
12/09/2003US6660847 Rheumatoid arthritis gene
12/09/2003US6660846 DNA fragment that encodes an amino acid synaptic vesicle transporter protein that is capable of effecting the passage of GABA into a synaptic vesicle
12/09/2003US6660845 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
12/09/2003US6660844 Optical sensors of cell signaling
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660842 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
12/09/2003US6660841 Activator of CREM in Testis and its uses
12/09/2003US6660840 Ability to stimulate a Th1 response in peripheral blood mononuclear cells; contain a biologically active portion of a Leishmania braziliensis
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660838 Compounds and methods for therapy and diagnosis of lung cancer
12/09/2003US6660835 Lead substances and their use as therapeutics
12/09/2003US6660834 Reagents useful for detecting diseases of the gastrointestinal tract
12/09/2003US6660833 A dimer of a synthetic lung surfactant protein B
12/09/2003US6660830 Peptides with antiproliferative properties
12/09/2003US6660714 α-O-linked glycoconjugates, methods of preparation and uses thereof
12/09/2003US6660521 Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
12/09/2003US6660520 Nrde
12/09/2003US6660513 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
12/09/2003US6660511 Screening for a bioactive agent capable of interfering with the binding of a Protein Phosphatase 5 (PP5) cell cycle protein to Rad9
12/09/2003US6660501 Production of proteins by cell culture
12/09/2003US6660500 Nucleotide sequences coding envelope protein for use in prevention of viral disease and parasitic infections
12/09/2003US6660499 Nucleic acid encoding human DCR5, a protein related to DAN (Differential-screening-selected gene Aberrative in Neuroblastoma)
12/09/2003US6660498 Malaria immunogenic composition
12/09/2003US6660497 Pectinophora gossypiella (pink bollworm) Bacillus thuringiensis toxin receptor BT-R2
12/09/2003US6660496 Nucleic acid molecules encoding a KOR3 kappa opioid receptor and the methods of producing the encoded receptor
12/09/2003US6660495 Tolerogenic fragments of natural allergens
12/09/2003US6660488 Antibodies for the alpha platelet-derived growth factor receptor
12/09/2003US6660479 Process for preparing peptide nucleic acid probe using polymeric photoacid generator
12/09/2003US6660474 Identifying individuals predisposed to essential hypertension and related conditions such as salt sensitivity by detecting the presence of polymorphic or mutant forms of the GRK4 gene, or its expression product.
12/09/2003US6660467 Variant of ciliary neurotrophic factor and DNA encoding the variant
12/09/2003US6660280 Collagen product containing collagen of marine origin with a low odor and preferably with improved mechanical properties, and its use in the form of cosmetic or pharmaceutical compositions or products
12/09/2003US6660276 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
12/09/2003US6660275 Amplification nucleic acids
12/09/2003US6660274 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
12/09/2003US6660273 Viable chimeric recombinant flavivirus
12/09/2003US6660272 For protection against Porcine Multisystemic Wasting Syndrome also called Post- weaning Multisystemic Wasting Syndrome
12/09/2003US6660271 Ubiquitin fusion-based vaccine system
12/09/2003US6660270 Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection
12/09/2003US6660269 Canine tropical pancytopenia;
12/09/2003US6660267 Prevention and treatment of sepsis
12/09/2003US6660261 Bordetella strain expressing the FHA hybrid, liposomes and vaccines
12/09/2003US6660259 Herpes simplex virus for treating unwanted hyperproliferative cell growth
12/09/2003US6660257 Flt-3 receptor agonist proteins; nucleic acid sequence
12/09/2003US6660256 Thrombocytopenia; the ligand stimulates the incorporation of labeled nucleotides (3H-thymidine) into the DNA of IL-3 dependant Ba/F3 cells transfected with human mpl P, and the amino-terminal sequence is SPAPPACDPRLLNKLLRDDHVLHGR (SEQ ID
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/09/2003US6659675 Document folder
12/09/2003CA2266543C Methods and compositions for identifying receptor effectors
12/09/2003CA2229955C Papilloma virus capsomere vaccine formulations and methods of use
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/09/2003CA2111580C Immunogen composites with noted anticytokin effect, process of preparation, pharmaceutical compositions and kits containing them
12/09/2003CA1341449C Poly-kringle plasminogen activator
12/04/2003WO2003100441A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 1 (sstr1)
12/04/2003WO2003100437A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
12/04/2003WO2003100432A2 Method for identifying immunoreactive peptides
12/04/2003WO2003100419A1 Methods for using the cd163 pathway for modulating an immune response
12/04/2003WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003WO2003100076A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria
12/04/2003WO2003100075A2 Bsnd nucleic acids and proteins
12/04/2003WO2003100065A1 Process for the mass production of silk protein and genetically modified silk-like protein having function imparted thereto
12/04/2003WO2003100063A1 A repressor-mediated regulation system for control of gene expression in plants
12/04/2003WO2003100062A1 Ehd1 GENE PROMOTING PLANT FLOEWERING AND UTILIZATION THEREOF
12/04/2003WO2003100061A2 Three finger toxin fold proteins
12/04/2003WO2003100060A2 Muc-1 antigen with reduced number of vntr repeat units
12/04/2003WO2003100054A1 Regulation of the formation of plant phragmoplast and method of constructing male sterile plant
12/04/2003WO2003100053A1 Compositions and methods for the treatment of hemophilia a
12/04/2003WO2003100042A1 Method for assembling sub units into capsoides
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100028A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
12/04/2003WO2003100027A2 Mutant fibronectin and tumor metastasis
12/04/2003WO2003100025A2 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
12/04/2003WO2003100022A2 Methods and dna constructs for high yield production of polypeptides
1 ... 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 ... 2916